Finding Solutions for Disparities Associated with Star Ratings
Finding Solutions for Disparities Associated with Star Ratings
批准号:
9978562
负责人:
Junling None Wang
金额:
$26.9万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-15 至 2023-06-30
关键词:
AddressAdherenceAmbulatory CareAreaBooksConcept InventoryCountyCross-Sectional StudiesDataData FilesDiabetes MellitusDiseaseDoseElderlyEmergency department visitEnrollmentEnsureGoalsGrantHealthHealth ExpendituresHealth PolicyHealth ResourcesHealth ServicesHealth StatusHospitalizationHyperlipidemiaHypertensionIncentivesIndividualLeadLength of StayLinkMeasuresMedicareMedicare Part AMedicare Part CMinorityMissionNational Institute on AgingNot Hispanic or LatinoOrangesOutcomePatientsPerformancePharmaceutical PreparationsPharmacy facilityPhysiciansPlayPoliciesPopulation HeterogeneityProceduresProliferatingQuality IndicatorRecommendationReportingResearch PersonnelRoleStretchingStructureSystemTestingUnited StatesUnited States Centers for Medicare and Medicaid ServicesUnited States Food and Drug AdministrationUnited States Health Resources and Services AdministrationVisitbasecostdisparity reductionethnic minority populationevidence basehealth disparityhealth planhospital readmissionimprovedmedication compliancenegative affectpaymentpopulation healthprogramsracial and ethnicracial and ethnic disparitiesresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Established by the Centers for Medicare & Medicaid Services (CMS), Star Ratings system for Medicare Parts
C&D (Star Ratings, hereafter) is a health plan quality reporting system with associated bonus payments and
enrollment incentives for health plans since 2012. Researchers have reported the disparity implications of Star
Ratings: e.g., racial/ethnic minorities are more likely to be excluded from measure calculation for diabetes
adherence than non-Hispanic whites, thus minorities may be more likely to be excluded from quality
improvement initiations for this measure, potentially worsening disparities in health. A critical barrier for
resolving such disparities is that comprehensive policy recommendation related to effects of Star Ratings on
racial/ethnic disparities is not available. The goals of this project are to ensure that Star Ratings include a set
of measures that address disparities in measure calculation, and to evaluate the effects of Star Ratings bonus
payments on reducing racial/ethnic disparities in medication utilization. Our strategies are to (1) add to Star
Ratings medication utilization measures selected from Pharmacy Quality Alliance measure concept inventory
(PMCI), and other commonly used medication utilization (CUMU) measures (Star Plus, hereafter), and (2)
compare racial/ethnic disparities in medication utilization before and after the implementation of bonus
payments, and between counties with “double bonuses” and those with regular bonuses. A project focusing on
only medication utilization measures in Star Ratings is warranted because these measures account for a high
percentage in Star Ratings scores (45% in Part D in 2013) and their correlation with other measures is only
moderate. Bonus payments are associated with improved plan benefit structure, which may reduce
racial/ethnic disparities in medication utilization. In the prior grant period we found that selecting appropriate
medication utilization measures may resolve racial/ethnic disparities associated with a Medicare Part D policy.
Our objective of this continuation project is to conduct an analysis of Medicare Parts A/B/D data (2010-2015),
linked to Area Health Resources Files, Orange Book Data Files, and CMS data on double/regular-bonus
counties. We will also conduct disease-specific analysis. Aim 1: Test the hypothesis that using the medication
utilization measures in current Star Ratings negatively affects the health of racial/ethnic minorities. Aim 2: Test
the hypothesis that using Star Plus can lead to a reduction in racial/ethnic disparities associated with Star
Ratings. Aim 3: Test the hypothesis that the Star Ratings bonus payments are associated with reduction in
racial/ethnic disparities in medication utilization. Our expected outcome is to provide policy recommendations
to resolve important disparity issues in Star Ratings among diverse older adults. Impact: This project will help
to align disparity reduction goals with rapidly-proliferating pay-for-performance and public-reporting initiatives.
This project is responsive to the National Institute on Aging's mission-driven strategic goal to “understand
health disparities and develop strategies to improve the health status of older adults in diverse populations.”
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Finding Solutions for Disparities Associated with Star Ratings
-
批准号:10418756
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2015
-
负责人:Junling None Wang
-
依托单位:
Finding Equitable and Effective MTM Eligibility Criteria
-
批准号:8854699
-
项目类别:
-
资助金额:$32.87万
-
财政年份:2015
-
负责人:Junling None Wang
-
依托单位:
Finding Solutions for Disparities Associated with Star Ratings
-
批准号:10217951
-
项目类别:
-
资助金额:$33.44万
-
财政年份:2015
-
负责人:Junling None Wang
-
依托单位:
Rectifying Disparities Associated with Risk Score-Based MTM Eligibility in Enhanced MTM
-
批准号:10734305
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2011
-
负责人:Junling None Wang
-
依托单位:
Equity and Economic Effects of MTM Services
-
批准号:10341080
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2011
-
负责人:Junling None Wang
-
依托单位:
Health Implications of MTM Eligibility Criteria
-
批准号:8161829
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2011
-
负责人:Junling None Wang
-
依托单位:
Health Implications of MTM Eligibility Criteria
-
批准号:8495841
-
项目类别:
-
资助金额:$28.27万
-
财政年份:2011
-
负责人:Junling None Wang
-
依托单位:
Health Implications of MTM Eligibility Criteria
-
批准号:8321965
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2011
-
负责人:Junling None Wang
-
依托单位:
海外基金